Efficacy and Safety of Lumasiran for Advanced Primary Hyperoxaluria Type 1: 24-Month Follow-up of the Phase 3 ILLUMINATE-C Trial
Anne-Laure Sellier-Leclerc MD , Daniella Magen MD , Hadas Shasha-Lavsky MD , Eva Simkova MD , Arnaud Devresse MD, PhD , Fitsum Guebre-Egziabher MD, PhD , Mini Michael MD , John C. Lieske MD , Yaacov Frishberg MD , Sevcan A. Bakkaloglu MD , Chebl Mourani MD , Rola Saqan MD , Richard Singer MBChB , Isabella Guzzo MD , Nune Makarova MD, MPH , Richard Willey MS , Cristin Kaspar MD , John M. Gansner MD, PhD , Jaap W. Groothoff MD, PhD
求助PDF
{"title":"Efficacy and Safety of Lumasiran for Advanced Primary Hyperoxaluria Type 1: 24-Month Follow-up of the Phase 3 ILLUMINATE-C Trial","authors":"Anne-Laure Sellier-Leclerc MD , Daniella Magen MD , Hadas Shasha-Lavsky MD , Eva Simkova MD , Arnaud Devresse MD, PhD , Fitsum Guebre-Egziabher MD, PhD , Mini Michael MD , John C. Lieske MD , Yaacov Frishberg MD , Sevcan A. Bakkaloglu MD , Chebl Mourani MD , Rola Saqan MD , Richard Singer MBChB , Isabella Guzzo MD , Nune Makarova MD, MPH , Richard Willey MS , Cristin Kaspar MD , John M. Gansner MD, PhD , Jaap W. Groothoff MD, PhD","doi":"10.1053/j.ajkd.2025.01.016","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":"86 2","pages":"Pages 285-288"},"PeriodicalIF":8.2000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Kidney Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0272638625007292","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/13 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
引用
批量引用
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
